491 related articles for article (PubMed ID: 18497941)
21. Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.
Mahajan A; Woo SY; Kornguth DG; Hughes D; Huh W; Chang EL; Herzog CE; Pelloski CE; Anderson P
Pediatr Blood Cancer; 2008 May; 50(5):976-82. PubMed ID: 18213710
[TBL] [Abstract][Full Text] [Related]
22. [A clinical study of the radiosensitization of aclarubicin].
Miyamoto T; Morita S; Asakawa H; Koyama T; Dokiya T; Kondo M; Yamashita T; Ohkawa T; Kanehira T
Gan No Rinsho; 1989 Mar; 35(4):472-6. PubMed ID: 2654441
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy With Hydrogen Peroxide-Soaked Gauze for Unresectable Breast Cancer.
Oike T; Tomizawa K; Adachi A; Wada M; Ohno T
Cureus; 2021 Oct; 13(10):e19167. PubMed ID: 34873510
[TBL] [Abstract][Full Text] [Related]
24. Combined radiotherapy and razoxane in the treatment of chondrosarcomas and chordomas.
Rhomberg W; Eiter H; Böhler F; Dertinger S
Anticancer Res; 2006; 26(3B):2407-11. PubMed ID: 16821624
[TBL] [Abstract][Full Text] [Related]
25. High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report.
Nakata M; Yoshida K; Shimbo T; Yoshikawa N; Yoshioka H; Hori A; Sato C; Uesugi Y; Kogata Y; Masui K; Murakami N; Kashihara T; Akiyama H; Tselis N; Ohmichi M; Nihei K
J Contemp Brachytherapy; 2020 Dec; 12(6):606-611. PubMed ID: 33437310
[TBL] [Abstract][Full Text] [Related]
26. Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer.
Ogawa Y; Kubota K; Aoyama N; Yamanishi T; Kariya S; Hamada N; Nogami M; Nishioka A; Onogawa M; Miyamura M
Cancers (Basel); 2015 Nov; 7(4):2277-89. PubMed ID: 26593948
[TBL] [Abstract][Full Text] [Related]
27. [High-dose multimodal radiotherapy of confluent destructively growing aggregated keratoacanthoma. 2 case reports].
Grevelhörster T; Micke O; Hampel G; Schönekaes K; Willich N
Strahlenther Onkol; 1996 Jul; 172(7):395-400. PubMed ID: 8693406
[TBL] [Abstract][Full Text] [Related]
28. [Present status of carbon ion radiotherapy for malignant tumors].
Sugahara S; Kamada T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1795-800. PubMed ID: 19920380
[TBL] [Abstract][Full Text] [Related]
29. Radiation sensitivity in vitro of primary tumors and metastatic lesions of malignant melanoma.
Rofstad EK
Cancer Res; 1992 Aug; 52(16):4453-7. PubMed ID: 1643637
[TBL] [Abstract][Full Text] [Related]
30. Treatment of locoregional metastases of malignant melanomas with radiotherapy and intralesional beta-interferon injection.
Paul E; Müller I; Renner H; Bödeker RH; Cochran AJ
Melanoma Res; 2003 Dec; 13(6):611-7. PubMed ID: 14646625
[TBL] [Abstract][Full Text] [Related]
31. KORTUC, a novel hydrogen peroxide‑based radiosensitizer for the enhancement of brachytherapy in patients with unresectable recurrent uterine cervical cancer.
Shimbo T; Yoshida K; Nakata M; Kobata K; Ogawa T; Kihara A; Sato C; Hori A; Takeno S; Yoshioka H; Akiyama H; Nihei K
Oncol Lett; 2023 Sep; 26(3):378. PubMed ID: 37559582
[TBL] [Abstract][Full Text] [Related]
32. Development of a Novel Enzyme-Targeting Radiosensitizer (New KORTUC) Using a Gelatin-Based Hydrogel Instead of a Sodium Hyaluronate.
Morita-Tokuhiro S; Ogawa Y; Yokota N; Tsuzuki A; Oda H; Ishida N; Aoyama N; Nishioka A
Cancers (Basel); 2016 Jan; 8(1):. PubMed ID: 26751477
[TBL] [Abstract][Full Text] [Related]
33. Critical organ preservation in reirradiation brachytherapy by injectable spacer.
Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885
[TBL] [Abstract][Full Text] [Related]
34. Non-surgical therapy and radiologic assessment of stage I breast cancer treatment with novel enzyme-targeting radiosensitization: Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, type II (KORTUC II).
Hitomi J; Kubota K; Ogawa Y; Hamada N; Murata Y; Nishioka A
Exp Ther Med; 2010 Sep; 1(5):769-775. PubMed ID: 22993600
[TBL] [Abstract][Full Text] [Related]
35. Primary malignant fibrous histiocytoma of the thyroid.
Zeng Q; Tang PZ; Xu ZG; Qi YF; Wu XX; Liu WS
Eur J Surg Oncol; 2009 Jun; 35(6):649-53. PubMed ID: 18922667
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation.
Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S
J BUON; 2008; 13(3):369-76. PubMed ID: 18979552
[TBL] [Abstract][Full Text] [Related]
37. Malignant fibrous histiocytoma of the sinonasal tract.
Wang CP; Chang YL; Ting LL; Yang TL; Ko JY; Lou PJ
Head Neck; 2009 Jan; 31(1):85-93. PubMed ID: 18853446
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
[TBL] [Abstract][Full Text] [Related]
39. Study of radiation dose fractionation in some tumor types.
Konecný M; Kudlicková Z; Malír A; Pecina J; Rasovská O; Spurný V
Czech Med; 1981; 4(3):174-82. PubMed ID: 7307850
[TBL] [Abstract][Full Text] [Related]
40. Topical sulindac combined with hydrogen peroxide in the treatment of actinic keratoses.
Resnick L; Rabinovitz H; Binninger D; Marchetti M; Weissbach H
J Drugs Dermatol; 2009 Jan; 8(1):29-32. PubMed ID: 19180893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
